← Open Payments lookup

GWENDOLYN DEJEAN: Open Payments

NPI 1578546487 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$279 in 10 payments from 6 companies in 2025. Trend: 2023 $25 · 2024 $104 · 2025 $279

Food & beverage: $279
CompanyPaymentsAmount
Otsuka Pharmaceutical Development & Commercialization, Inc.1$107
Otsuka America Pharmaceutical, Inc.3$55
Neurocrine BioSciences, Inc.2$48
ABBVIE INC.2$29
Teva Pharmaceuticals USA, Inc.1$24
Vanda Pharmaceuticals Inc.1$15

Products named: REJOYN, REXULTI, INGREZZA, VRAYLAR, UZEDY, FANAPT.

Industry payments across TX — which companies pay providers there.